Abstract
While there are increasing reports of acute kidney injury among hospitalized adults with COVID-19, there is still limited information on renal complications associated with COVID-19 in children. The cause of kidney involvement in COVID-19 is likely multifactorial, and appears to involve a complex process, including complement dysregulation and thrombotic microangiopathy. We present a pediatric case of COVID-19 and renal failure due to thombotic microangiopathy, successfully treated with eculizumab.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1373-1376 |
| Number of pages | 4 |
| Journal | Journal of Nephrology |
| Volume | 33 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2020 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020, Italian Society of Nephrology.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Eculizumab treatment for renal failure in a pediatric patient with COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS